Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Interest Coverage Ratio (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Interest Coverage Ratio for 4 consecutive years, with 3.93 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Coverage Ratio rose 78.62% year-over-year to 3.93, compared with a TTM value of 6.7 through Sep 2025, up 124.37%, and an annual FY2024 reading of 18.08, up 65.38% over the prior year.
  • Interest Coverage Ratio was 3.93 for Q3 2025 at Atara Biotherapeutics, down from 3.29 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 38.15 in Q1 2025 and bottomed at 22055.0 in Q1 2022.
  • Average Interest Coverage Ratio over 4 years is 1592.07, with a median of 49.9 recorded in 2023.
  • The sharpest move saw Interest Coverage Ratio soared 51.74% in 2024, then skyrocketed 240.78% in 2025.
  • Year by year, Interest Coverage Ratio stood at 645.63 in 2022, then surged by 92.1% to 50.99 in 2023, then surged by 76.47% to 12.0 in 2024, then surged by 67.23% to 3.93 in 2025.
  • Business Quant data shows Interest Coverage Ratio for ATRA at 3.93 in Q3 2025, 3.29 in Q2 2025, and 38.15 in Q1 2025.